Comparison of NEWS2 and Machine Learning for Early Sepsis Warning
Key facts
- Who runs it
- Kocaeli Derince Education and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 100 people, planned
- Started
- 22 Jul 2026
- Ended
- 13 Aug 2026
- Type of study
- Observational
- Treatments tested
- Observational Study - No Intervention
- Record updated
- 13 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patients aged 18 years and older
- Admitted to Kocaeli City Hospital Anesthesiology and Reanimation Clinic
- Suspected infection at the time of hospital admission
- Complete vital signs recorded
- Informed consent obtained from the patient or legal representative
Who cannot take part
- Patients with chronic kidney disease requiring dialysis
- Patients with a history of organ transplantation
- Patients under 18 years of age
- Pregnant patients
- Patients with incomplete data
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This prospective observational study aims to objectively measure the lead-time (the time from the first KDS alert to sepsis diagnosis) of the NEWS2-based clinical decision support system (KDS) and compare its early warning performance with a machine learning model trained on 2000 patients and externally validated. The study seeks to answer the following main questions:
Read full original descriptionShow less
How early does the NEWS2-based KDS provide an alert before sepsis diagnosis?
Does a machine learning model, developed using logistic regression and externally validated in a prospective cohort, offer superior specificity and comparable sensitivity to KDS?
Participants who are already receiving routine clinical care at Kocaeli City Hospital will have their vital signs and laboratory data monitored as part of standard practice. NEWS2 scores will be calculated automatically and the time of the first alert (T0) will be recorded. Sepsis diagnosis will be confirmed by an increase in SOFA score ≥ 2 (T1), evaluated by two independent and blinded physicians. Lead-time will be calculated as the difference between T1 (hours×60) and T0 (minutes). The machine learning model will be tested prospectively on this cohort, and its performance will be compared with KDS using sensitivity, specificity, F1 score, ROC-AUC, and accuracy.
Treatments tested
- Observational Study - No Intervention
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparison of NEWS2 and a Machine Learning Model for Early Sepsis Warning: A Prospective Observational Study
- Record updated
- 13 August 2026